aldosterone has been researched along with Parkinson Disease in 9 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Low blood pressure is frequent in the akinetic form of Parkinson's disease." | 1.25 | Renin-aldosterone system in Parkinson's disease. ( Barbeau, A; Boucher, R; Genest, J; Gillo-Joffroy, L; Nowaczynski, W, 1969) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, DJ | 1 |
| Mendelsohn, FA | 1 |
| Adam, WR | 1 |
| Funder, JW | 1 |
| Karimova, MKh | 1 |
| Vartanian, KZ | 1 |
| Petelin, LS | 1 |
| Kubatiev, AA | 1 |
| Granérus, AK | 1 |
| Jagenburg, R | 1 |
| Svanborg, A | 1 |
| Wilcox, CS | 1 |
| Aminoff, MJ | 1 |
| Slater, JD | 1 |
| Bannister, R | 1 |
| Siegenthaler, W | 1 |
| Werning, C | 1 |
| Barbeau, A | 2 |
| Brossard, Y | 1 |
| Kuchel, O | 1 |
| Cuche, JL | 1 |
| Boucher, R | 2 |
| Genest, J | 2 |
| Sullivan, JM | 1 |
| Nakano, KK | 1 |
| Tyler, HR | 1 |
| Gillo-Joffroy, L | 1 |
| Nowaczynski, W | 1 |
3 reviews available for aldosterone and Parkinson Disease
| Article | Year |
|---|---|
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; | 1981 |
Degeneration of the autonomic nervous system.
Topics: Acute Disease; Adie Syndrome; Aldosterone; Animals; Autonomic Nervous System; Blood Volume; Bulbar P | 1971 |
[Renin-angiotensin-aldosterone system from the clinical viewpoint].
Topics: Addison Disease; Aldosterone; Angiotensin II; Cushing Syndrome; Female; Humans; Hyperaldosteronism; | 1970 |
1 trial available for aldosterone and Parkinson Disease
| Article | Year |
|---|---|
[Effect of veroshpiron on hormone level in patients with Parkinson's disease].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Humans; Middle Aged; Parkinson Disease; Spironola | 1994 |
5 other studies available for aldosterone and Parkinson Disease
| Article | Year |
|---|---|
Kaliuretic effect of L-dopa treatment in parkinsonian patients.
Topics: Aged; Aldosterone; Blood Pressure; Carboxy-Lyases; Diuresis; Female; Glomerular Filtration Rate; Hum | 1977 |
Sodium homeostasis in patients with autonomic failure.
Topics: Aldosterone; Diet; Fludrocortisone; Homeostasis; Humans; Hypotension, Orthostatic; Nervous System Di | 1977 |
Dopamine and blood pressure.
Topics: Aldosterone; Angiotensin II; Basal Ganglia; Blood Pressure; Circadian Rhythm; Dopamine; Humans; Kidn | 1970 |
Plasma renin activity during levodopa therapy. Significance of long- and short-term treatment.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Animals; Blood Pressure; Diet; Dihydroxyphenylalanine; Fem | 1973 |
Renin-aldosterone system in Parkinson's disease.
Topics: Aldosterone; Catecholamines; Dihydroxyphenylalanine; Female; Humans; Hypotension; Male; Middle Aged; | 1969 |